As of March 1, 2016, Independence has new preferred providers for
both our Direct Ship Drug Program and intravenous and subcutaneous
immunoglobulin (IVIG/SCIG) drugs provided in the home. These changes do not
affect medical necessity criteria or coverage determinations for our
members.
Direct Ship Drug Program
Walgreens and PerformSpecialty (referred to in previous Independence
communications as PerformRx), independent companies, were chosen as preferred
providers for our Direct Ship Drug Program. All requests for direct ship drugs
will be fulfilled by these providers, with the exception of
Synagis®, which will continue to be fulfilled by ACRO
Pharmaceutical Services, an independent company.
For more information on ordering drugs through our Direct Ship Drug Program webpage.
IVIG/SCIG home infusion
Option Care, an independent company, was selected as the preferred provider
for IVIG/SCIG drugs given in the home.
The following communications occurred for this change:
- Independence sent letters to affected members notifying them that Option
Care is the preferred home infusion vendor for IVIG/SCIG and detailing the
transition plan of service.
- Option Care provided outreach to affected members to answer questions and
schedule appointments with an Option Care home infusion nurse.
- Option Care contacted affected vendors to answer questions and obtain new
prescriptions for our members.
Members who start home infusion therapy with IVIG/SCIG drugs on or after
March 1, 2016, should receive such services from either Option Care or a home
infusion vendor that is owned by a hospital or health system that participates
in the Independence provider network.
Providers should talk to their Independence members who currently receive
IVIG/SCIG drugs at home to see if they have any questions or concerns.
Note: Members who currently receive IVIG/SCIG drugs through home
infusion vendors that are owned by a hospital or health system that
participates in the Independence provider network are not affected by this
change.